Cell-specific mechanisms drive connectivity across the time course of Huntington's disease.
Saved in:
| Title: | Cell-specific mechanisms drive connectivity across the time course of Huntington's disease. |
|---|---|
| Authors: | Estevez-Fraga C; Department of Neurodegenerative Disease, University College London, London, UK. estevezfragacarlos@gmail.com., Sebenius I; Department of Psychiatry, University of Cambridge, Cambridge, UK.; Department of Computer Science and Technology, University of Cambridge, Cambridge, UK., Hansen JY; McConnell Brain Imaging Centre, Montréal Neurological Institute, McGill University, Montréal, QC, Canada., Hänisch B; Department of Psychiatry and Psychotherapy, University Hospital Tübingen, Tübingen, Germany.; German Centre for Mental Health, Tübingen, Germany.; Max Planck School of Cognition, Leipzig, Germany., Zeun P; Southampton General Hospital, Southampton, UK., Scahill RI; Department of Neurodegenerative Disease, University College London, London, UK., Gregory S; Department of Neurodegenerative Disease, University College London, London, UK., Johnson EB; Department for Science Innovation and Technology, London, UK., Wild EJ; Department of Neurodegenerative Disease, University College London, London, UK., Byrne LM; Department of Neurodegenerative Disease, University College London, London, UK., Durr A; Sorbonne Université, Paris Brain Institute (ICM), AP-HP, Inserm, CNRS, Pitié-Salpêtrière University Hospital, Paris, France., Landwehrmeyer B; University of Ulm, Ulm, Germany., Leavitt BR; Department of Medical Genetics, Centre for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, BC, Canada.; UBC Children's Hospital, Vancouver, BC, Canada., Misic B; McConnell Brain Imaging Centre, Montréal Neurological Institute, McGill University, Montréal, QC, Canada., Valk SL; Institute of Neuroscience and Medicine, Research Centre Jülich, Jülich, Germany.; Institute of Systems Neuroscience, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.; Otto Hahn Group 'Cognitive Neurogenetics', Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany., Rees G; Wellcome Centre for Human Neuroimaging, UCL Queen Square Institute of Neurology, University College London, London, UK., Tabrizi SJ; Department of Neurodegenerative Disease, University College London, London, UK. s.tabrizi@ucl.ac.uk., McColgan P; Department of Neurodegenerative Disease, University College London, London, UK.; Roche Pharma Research and Early Development (pRED), F. Hoffmann-La Roche Ltd., Basel, Switzerland. |
| Source: | Nature communications [Nat Commun] 2025 Jul 01; Vol. 16 (1), pp. 5519. Date of Electronic Publication: 2025 Jul 01. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
